ROGER J. BULGER, M.D.; SHELDON SIDELL, M.D.; WILLIAM M. M. KIRBY, M.D.
Gentamicin1 is a new broad-spectrum antibiotic that offers promise in the treatment of infections caused by a wide variety of gram-negative rods. It is an antibiotic mixture of two isomers that share the same antibacterial and pharmacologic principles (1) and that has been isolated by Weinstein and coworkers (2) from two previously undescribed microorganisms of the genus Micromonospora. These two species are called Micromonospora pupurea n. sp. and Micromonospora echinospora n. sp. Gentamicin has been extensively investigated in our laboratory and in a number of patients, several of whom received careful pharmacologic studies at the Clinical Research Center of the
BULGER RJ, SIDELL S, KIRBY WMM. Laboratory and Clinical Studies of Gentamicin: A New Broad-spectrum Antibiotic. Ann Intern Med. ;59:593–604. doi: 10.7326/0003-4819-59-5-593
Download citation file:
Published: Ann Intern Med. 1963;59(5_Part_1):593-604.
Hospital Medicine, Nephrology, Urological Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use